Send to a Friend
Microsulis Medical Limited
| Parent Company | N/A |
| Product Range | Microwave Tissue Ablation (‘MTA’) and Microwave Tubal Occlusion (‘MTO’), |
| Operation | Microsulis’ strategy is to derive revenue growth both from increasing the market share of its existing products as well as through the introduction of new products. The Company is currently focused on the development of a number of new products including specific research on: Microwave Fibroid Debulking, Microwave Endometriosis Treatment, Microwave Ablation of Renal Cancer, Microwave Ablation of Prostate Cancer and Benign Prostate Hyperplasia (BPH), Microwave Ablation of Brain Tumours, Microwave Assisted Drug Delivery, Microwave Psoriasis Treatment, Microwave Varicose Veins Treatment. The Company is also researching further product developments related to application of small diameter flexible applicators and treatment of general skin conditions in addition to possible research into cutaneous leishmaniasis. |
| Contact | N/A |
| Address | Herriot Watt University Research Park Centre for Research & Product Development EH14 4AP |
| Phone | +44 (0) 131 449 8750 |
| Fax | +44 (0) 131 449 8787 |
| info@microsulis.com | |
| Web | http://www.microsulis.co.uk/ |
| Nationality | N/A |
| Employees | N/A |
| Turnover | N/A |
